June 27, 2017

US Bioservices is now dispensing RITUXAN HYCELA

The U.S. Food and Drug Administration has approved RITUXAN HYCELA (rituximab and hyaluronidase human) for subcutaneous injection for the treatment of adults with specific forms of lymphoma and leukemia.